The cost of Ubrelvy (ubrogepant) without insurance can vary significantly depending on factors such as pharmacy, location, and available discounts or coupons. Without insurance, the out-of-pocket cost for Ubrelvy can be substantial.
What is the typical cash price for Ubrelvy?
The list price for a 24-count prescription of Ubrelvy can range from approximately $4,000 to over $5,000 [1]. This is a general estimate, and actual prices may differ.
Are there ways to reduce the cost of Ubrelvy without insurance?
Patients seeking to lower the cost of Ubrelvy may be able to utilize savings cards or discount programs offered by the manufacturer or third-party discount providers. These programs can sometimes reduce the out-of-pocket expense to a more manageable level, potentially as low as $30 per prescription [2]. However, eligibility and the extent of savings can vary.
What is Ubrelvy and what is it used for?
Ubrelvy is an oral medication approved for the acute treatment of migraine with or without aura in adults [1]. It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) receptor antagonists.
How does Ubrelvy work?
Ubrelvy works by blocking the action of CGRP, a molecule that is thought to play a role in migraine pain [1]. By inhibiting CGRP, the medication helps to reduce migraine symptoms.
How does Ubrelvy compare to other migraine treatments?
Ubrelvy is an acute treatment, meaning it is taken during a migraine attack to relieve symptoms. It is distinct from preventive migraine medications, which are taken regularly to reduce the frequency and severity of migraines. Other acute migraine treatments include triptans and other CGRP inhibitors.
What are the potential side effects of Ubrelvy?
Common side effects associated with Ubrelvy can include nausea, fatigue, and dry mouth [1].
What is the patent status of Ubrelvy?
Information on the specific patent expiration dates for Ubrelvy is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [3]. Patent status can influence the availability of generic alternatives and, consequently, drug pricing.
---
Sources:
[1] Ubrelvy. https://www.ubrelvy.com/
[2] Ubrelvy Savings Card. https://www.ubrelvy.com/savings-card
[3] DrugPatentWatch.com. https://drugpatentwatch.com/